NCT03577990

Brief Summary

Hypertension (HTN) is a global problem affecting 972 million adults and an important public health burden since it is the main cause of cardiovascular disease and death, and the second leading cause of disability. Disproportionately affected, Black women have the highest prevalence of HTN in the United States. This research will evaluate potential interventions for possible community-based strategies for controlling HTN using interactive self-care strategies with coaching and technology. We hypothesize that participants who receive the Chronic Disease Self-Management Program (CDSMP) workshop and Interactive Technology Enhanced Coaching (ITEC) will have lower systolic/diastolic blood pressure (BP) and better adherence to antihypertensive medication(s) and lifestyle recommendations (physical activity, diet, and weight management) post intervention compared to participants receiving self-care management alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 5, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

January 28, 2019

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2021

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

May 17, 2023

Completed
Last Updated

May 17, 2023

Status Verified

April 1, 2023

Enrollment Period

2.2 years

First QC Date

April 18, 2018

Results QC Date

November 23, 2022

Last Update Submit

April 23, 2023

Conditions

Keywords

hypertension, Black women, self-management, coaching

Outcome Measures

Primary Outcomes (1)

  • Change in Systolic and Diastolic Blood Pressure (BP)

    To show the change (decrease) in systolic blood pressure (SBP) and diastolic blood pressure (DBP) over 9 months.

    Baseline to 3 months, 6 months, and 9 months.

Secondary Outcomes (5)

  • Medication Adherence by Proportion of Days Covered

    Month 1 to Month 3, Month 6, and Month 9.

  • Physical Activity (Change in Daily Steps)

    Month 1 to Month 3, Month 6, and Month 9.

  • Change in Dietary Intake (Calories)

    Month 1 to Month 3, Month 6, and Month 9.

  • Change in Weight

    Baseline to 3 months, 6 months, and 9 months.

  • Change in Dietary Intake (Sodium)

    Month 1 to Month 3, Month 6, and Month 9.

Other Outcomes (1)

  • Stigma and Hypertension, Qualitative Study

    15 minutes

Study Arms (2)

Interactive Technology Enhanced Coaching (ITEC)

EXPERIMENTAL

Fitbit Plus monitoring will include BP, weight measurements, daily food intake, self-report medication-taking, and physical activity plus weekly Interactive Technology-Enhanced Coaching (ITEC) for 3 months, then biweekly ITEC for 3 months, followed by another 3 months with no coaching to assess for sustainability.

Behavioral: Interactive Technology Enhanced Coaching (ITEC)

Interactive Technology-No Coaching (IT)

ACTIVE COMPARATOR

Participants will receive usual care for 3 months followed by 6 months of only Fitbit Plus monitoring (with no ITEC) of BP, weight measurements, daily food intake, self-report medication-taking, and physical activity to be used for comparative data with the treatment arm.

Behavioral: Interactive Technology-No Coaching (IT)

Interventions

As participants wear the activity tracker, take their BP and weight, along with input of food intake and medication-taking, data is transmitted in real time via Bluetooth Smart technology to the Fitbit Plus dashboard. All data is tracked, analyzed, and transparently displayed for participants to view and better understand their condition, and actively engage in self-care. Staff monitor data and communicate with participants to encourage active engagement in action plans by sending tailored coaching messages (ITEC) via the Fitbit Plus dashboard to the treatment arm weekly for 3 months, and biweekly for 3 months to motivate and support (BP control, medication adherence, and lifestyle modifications). After 6 months, the treatment arm will be monitored an additional 3 months with no tailored coaching for sustainability.

Interactive Technology Enhanced Coaching (ITEC)

After receiving usual care for 3 months, the control arm will receive the same electronic monitoring as the treatment arm and data will be captured in the same manner with the Fitbit Plus dashboard. Participants will be expected to use the information from the dashboard and the CDSMP workshop as a guide to self-care without coaching (IT). Staff will only monitor data. Control participants will not be contacted between repeated measures data collection periods, except to send reminders if they are not participating daily.

Interactive Technology-No Coaching (IT)

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identified as Black or African American;
  • years of age
  • English speaking
  • Has to live in the study community, Charlotte or surrounding area
  • Systolic BP greater than or equal to 130 and/or diastolic BP greater than or equal to 80 at screening
  • Prescribed to take one or more antihypertensive medication(s)
  • Smartphone or device
  • Bluetooth 4.0 and Provider network or Wi-Fi connectivity

You may not qualify if:

  • Self-report of mental illness that interferes with daily functioning
  • Unable to be physically active
  • Current pregnancy
  • Plans to move from the study area during the project
  • Systolic BP greater than or equal to 160 and/or diastolic BP greater than or equal to 100
  • Uncontrolled diabetes (HbA1c \>8.5), hemodialysis, stroke (within past year with residual effects such as weakness, paralysis, speech difficulty, etc.), cancer treatment (for spread of cancer to other places in the body), or a heart attack (within the past year)
  • Concurrent participation in another research study and/or taken any Stanford self-management program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Churches, Salons, Community Events

Charlotte, North Carolina, 28223, United States

Location

Related Publications (2)

  • Abel WM, Spikes T, Greer DB. A Qualitative Study: Hypertension Stigma Among Black Women: Erratum. J Cardiovasc Nurs. 2025 May-Jun 01;40(3):279. doi: 10.1097/JCN.0000000000001213. No abstract available.

  • Abel WM, DeHaven MJ. An interactive technology enhanced coaching intervention for Black women with hypertension: Randomized controlled trial study protocol. Res Nurs Health. 2021 Feb;44(1):24-36. doi: 10.1002/nur.22090. Epub 2020 Dec 15.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Willie M. Abel, Associate Professor of Nursing
Organization
The University of North Carolina at Charlotte

Study Officials

  • Willie M Abel, PhD

    The University of North Carolina at Charlotte

    PRINCIPAL INVESTIGATOR
  • Mark J DeHaven, PhD

    The University of North Carolina at Charlotte

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study will test the effects of ITEC added to CDSMP on two study aims: 1) BP control, and 2) adherence to antihypertensive medication and lifestyle modifications. After baseline data collection, participants complete a 6-week CDSMP course and then are randomly assigned to either the treatment or control arm. All participants will continue to receive usual care for HTN. The treatment group will receive ITEC and wireless tools to track activity, BP, weight, food intake, and self-report medication-taking after an orientation to Fitbit Plus (a cloud-based collaborative care platform designed to store and track data). All tools will be synced to the participants' smartphone. The treatment arm will receive weekly ITEC for 3 months, biweekly ITEC for 3 months, and then no ITEC for 3 months. The control arm will receive usual care only with monthly BP measured manually for 3 months and then receive the same wireless tools with monitoring to track comparative data with the treatment arm.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 18, 2018

First Posted

July 5, 2018

Study Start

January 28, 2019

Primary Completion

April 16, 2021

Study Completion

April 16, 2021

Last Updated

May 17, 2023

Results First Posted

May 17, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations